Clinical trial
A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients
NCT00494611 · St. Luke's-Roosevelt Hospital Center, Other · Terminated
Key facts
| NCT number | NCT00494611 |
|---|---|
| Title | A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients |
| Official title | A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients |
| Lead sponsor | St. Luke's-Roosevelt Hospital Center, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colon Cancer |
| Intervention type | Drug |
| Interventions | Peri operative Cetuximab. |
| Enrollment | 25 |
| Start date | Sep 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jul 2, 2007 |
| Last update posted | May 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: